 AIM ImmunoTech Inc NYSE:AIM said the Delaware Court of Chancery has denied an activist investors bid to put two nominees on its board during the November 3 annual meeting of shareholders. In its decision, the court denied Jonathan Jorgls motion for a mandatory preliminary injunction that sought to require the AIM board of directors to accept his director nominations and include his nominees on a universal proxy card. 